fda stop tirzepatide Trade association opposes decision to remove weight-loss drugs from shortage list Compounded Tirzepatide: Legal & Safe

Personalized care program designed to maximize the longevity benefits of GLP-1s.

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

Semaglutide labels include a thyroid cancer warning

Semaglutide has soared in popularity: within months of its distribution, the US reported shortages

Request it today.

Semaglutide weight loss in Lehigh Valley at Azani Medical Spa helps support appetite control and medically guided weight management.